CA
NZ
UK
AU
IND
US
Randy Lee Stone, a director of CTS Corp, filed a statement of changes in beneficial ownership on November 9, 2026, reporting the acquisition of 2,813 restricted stock units on November 5, 2026, at a price of $0.
Director Donna Costello filed a Form 4 with the SEC on November 9, 2026, disclosing the acquisition of 2,813 restricted stock units of CTS Corp on November 5, 2026.
Director Amy M. Dodrill filed a Form 4 with the SEC on November 9, 2026, disclosing the acquisition of 2,813 restricted stock units of CTS Corp on November 5, 2026.
Director William S. Johnson filed a Form 4 with the SEC on November 9, 2026, disclosing the acquisition of 2,813 restricted stock units of CTS Corp on November 5, 2026.
Director Robert Profusek filed a Form 4 with the SEC on November 9, 2026, reporting the acquisition of 2,813 restricted stock units of CTS Corp on November 5, 2026, at no cost.
Director Alfonso G. Zulueta filed a Form 4 with the SEC on November 9, 2026, disclosing the acquisition of 2,813 restricted stock units of CTS Corp on November 5, 2026, at no cost.
SOPHiA GENETICS SA Chief Executive Officer and Director Ross Muken filed a Form 4 on November 9, 2026, disclosing an open-market purchase of 20,000 ordinary shares on November 6, 2026.
Director Thomas M. Krummel of California Water Service Group filed a statement of changes in beneficial ownership on November 9, 2026, reporting a sale of common stock executed on November 6, 2026.
Director Nailesh Bhatt of Hyperliquid Strategies Inc filed a Statement of Changes in Beneficial Ownership on November 9, 2026, disclosing the acquisition of 17,123 restricted stock units on November 5, 2026.
George Cardoza, Chief Financial Officer of SOPHiA GENETICS SA, filed a Form 4 on November 9, 2026, disclosing an open-market purchase of 20,000 ordinary shares on November 6, 2026.
Please wait processing your request...